@MISC{noauthor_undated-wr,
  title        = "Pharmacovigilance",
  url = {https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance},
  note         = "Accessed: 2022-1-25",
  language     = "en"
}

@article{Maity2021,
	title = {Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database},
	author = {Maity, Tuhin and Longo, Christopher},
	year = {2021},
	month = {11},
	date = {2021-11-13},
	journal = {BMC Health Services Research},
	volume = {21},
	number = {1},
	doi = {10.1186/s12913-021-07260-z},
	url = {http://dx.doi.org/10.1186/s12913-021-07260-z},
	langid = {en}
}


@ARTICLE{Desai2021-dh,
  title    = "Broadening the reach of the {FDA} Sentinel system: A roadmap for
              integrating electronic health record data in a causal analysis
              framework",
  author   = "Desai, Rishi J and Matheny, Michael E and Johnson, Kevin and
              Marsolo, Keith and Curtis, Lesley H and Nelson, Jennifer C and
              Heagerty, Patrick J and Maro, Judith and Brown, Jeffery and Toh,
              Sengwee and Nguyen, Michael and Ball, Robert and Pan, Gerald Dal
              and Wang, Shirley V and Gagne, Joshua J and Schneeweiss,
              Sebastian",
  journal  = "NPJ digital medicine",
  volume   =  4,
  number   =  1,
  pages    = "170",
  month    =  dec,
  year     =  2021,
  language = "en",
  issn     = "2398-6352",
  pmid     = "34931012",
  doi      = "10.1038/s41746-021-00542-0"
}
